Strive, Inc. (ASST), based in Dallas, describes itself as the first publicly traded asset management Bitcoin treasury company, focused on increasing Bitcoin per share over the long run. Its analyst price target set is small but uniformly bullish. Five current targets were reviewed: Maxim Group at $37 (October 2026), B. Riley Securities at $33 (September 2026), TD Cowen at $44 (September 2026), StoneX at $32 (June 2026), and H.C. Wainwright at $38 (May 2026).
These five figures average $36.80, rounded to a $37 central target, within a $32-to-$44 range. The wide spread reflects genuine disagreement about how to value a company whose results are dominated by Bitcoin's price rather than conventional earnings. TD Cowen's higher target and recent raises across the group have followed Strive's moves to broaden investor demand, including daily dividends on its perpetual preferred "SATA" shares, which analysts have framed as a capital-efficiency tool to accelerate Bitcoin accumulation per share. Even the lowest target sits modestly above the current price, a sign of optimism rather than caution across coverage.
ASST closed at $28.97 on its most recent session, with a 52-week range of roughly $7.02 to $36.20 that underscores how volatile the shares have been. Reaching $37 requires a gain of about 28%, a substantial move rather than a marginal step. The path is heavily dependent on Bitcoin. Because Strive's balance sheet and income statement are marked to the cryptocurrency's price, the stock forecast effectively follows Bitcoin's trajectory, amplified by leverage and preferred-share issuance. The company reported only about $8.5 million in trailing revenue and a large net loss driven by mark-to-market swings, so traditional valuation metrics provide limited guidance.
The stock's prior 52-week high near $36.20 sits just below the $37 target, making that zone a key resistance level. A close above it would mark a new multi-month high. On the downside, the $22-to-$24 area, where the shares found footing in mid-October, is a notable support level, with the round-number $30 level acting as near-term psychological resistance. These levels matter because the shares tend to trend with Bitcoin, and breakouts or breakdowns in either asset tend to reinforce the other.
Analyst targets generally reflect a research horizon of roughly 12 months, though the exact horizon can differ by firm and none of the five reports reviewed specifies a guaranteed timeframe. Investors should monitor Bitcoin's price closely, along with Strive's upcoming earnings (estimated around November 10), any updates to preferred-share issuance and Bitcoin-per-share metrics, analyst revisions, and broader risk appetite and interest-rate conditions that influence speculative assets.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a volatile, Bitcoin-linked name like ASST, such tools can help traders discover opportunities, monitor positions, and spot shifting trends more efficiently than manual chart review alone. Traders evaluating whether Strive can sustain momentum toward its target may find the signal stream a useful complement to fundamental research.
The $37 central target, an average of five analyst price targets, implies roughly a 28% advance from the latest close of $28.97. It is a plausible but far-from-guaranteed objective: the setup rests almost entirely on Bitcoin's trajectory, with analysts uniformly bullish but divided over valuation, as the $32-to-$44 range shows. Rising Bitcoin and accretive accumulation would support the move, while a crypto drawdown, dilution, or thin underlying earnings could keep the shares well short of the target. Investors should watch Bitcoin's price, the Bitcoin-per-share metric, and upcoming earnings for the clearest signal of which direction dominates next.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, ASST has been closely correlated with DFDV. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if ASST jumps, then DFDV could also see price increases.
| Ticker / NAME | Correlation To ASST | 1D Price Change % | ||
|---|---|---|---|---|
| ASST | 100% | -10.17% | ||
| DFDV - ASST | 69% Closely correlated | -15.01% | ||
| FWDI - ASST | 62% Loosely correlated | -11.35% | ||
| HSDT - ASST | 59% Loosely correlated | -8.10% | ||
| STKE - ASST | 55% Loosely correlated | -6.45% | ||
| IVZ - ASST | 41% Loosely correlated | -8.02% | ||
More | ||||
| Ticker / NAME | Correlation To ASST | 1D Price Change % |
|---|---|---|
| ASST | 100% | -10.17% |
| ASST (2 stocks) | 98% Closely correlated | +4.92% |
| Investment Managers (136 stocks) | 43% Loosely correlated | +0.23% |